Management of cytologic abnormalities in patients younger than 25 years

This algorithm describes management of cytologic abnormalities in patients younger than 25 years.

ASC-US: atypical squamous cells of undetermined significance; LSIL: low-grade squamous intraepithelial lesion; ASC-H: atypical squamous cells cannot exclude HSIL; HSIL: high-grade squamous intraepithelial lesion; HPV: human papillomavirus; NILM: negative for intraepithelial lesion or malignancy; AGC: atypical glandular cell.
* Cytology if age <25 years; HPV-based testing if ≥25 years.

From: Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020; 24:102. DOI: 10.1097/LGT.0000000000000525. Copyright © 2020 the American Society for Colposcopy and Cervical Pathology. Reproduced with permission from Wolters Kluwer Health. Unauthorized reproduction of this material is prohibited.

Graphic 127913 Version 3.0

خرید پکیج

Management of cytologic abnormalities in patients younger than 25 years